Table 2.
Description of clinical characteristics of the study population by clinic type
| NA/NT | Overall | Primary care public clinic | Secondary care public hospital | Private clinic/hospital | |||||
|---|---|---|---|---|---|---|---|---|---|
| N | Median (IQR) or % | N | Median (IQR) or % | N | Median (IQR) or % | N | Median (IQR) or % | ||
| Height (cm) | 12 NA | 288 | 165 (156–172) | 99 | 164 (154–170) | 91 | 166 (159–173) | 98 | 167 (156–172) |
| Weight (kg) | 8 NA | 292 | 82 (72–94) | 99 | 77 (69–89) | 93 | 84 (75–94) | 100 | 86 (75–97) |
| Body mass index (kg/m2) | 13 NA | 287 | 30.4 (27.0–34.5) | 98 | 29.5 (26.0–33.9) | 91 | 30.0 (27.0–34.0) | 98 | 31.3 (27.5–35.4) |
| Systolic blood pressure (mmHg) | 3 NA | 297 | 130 (120–140) | 99 | 130 (125–139) | 98 | 124 (116–136) | 100 | 128 (120–140) |
| Diastolic blood pressure (mmHg) | 3 NA | 297 | 75 (70–80) | 99 | 80 (70–80) | 98 | 71 (66–80) | 100 | 80 (70–80) |
| HbA1C (%) | 8 NA/1 NT | 291 | 7.4 (6.6–8.6) | 92 | 7.2 (6.7–8.3) | 100 | 7.8 (7.0–8.6) | 99 | 7.1 (6.4–8.7) |
| Total cholesterol (mg/dl) | 11 NA/4 NT | 285 | 151 (128–193) | 96 | 154 (131–189) | 98 | 133 (116–163) | 91 | 178 (148–228) |
| LDL (mg/dl) | 18 NA/3 NT | 279 | 85 (59–120) | 94 | 87 (61–115) | 98 | 66 (54–93) | 87 | 101 (81–147) |
| HDL (mg/dl) | 21 NA/4 NT | 275 | 43 (35–50) | 91 | 43 (36–50) | 98 | 43 (35–50) | 86 | 41 (35–49) |
| Triglycerides (mg/dl) | 19 NA/4 NT | 277 | 131 (89–177) | 95 | 131 (97–168) | 98 | 115 (80–162) | 84 | 142 (103–221) |
| Serum creatinine (mg/dl) | 11 NA/3 NT | 286 | 0.83 (0.70–1.03) | 96 | 0.8 (0.6–0.9) | 98 | 0.9 (0.7–1.3) | 92 | 0.8 (0.7–1.0) |
| Urinary albumin/creatinine ratio (mg/g) | 54 NA/64 NT | 182 | 17.1 (5.6–85.7) | 46 | 27 (5.1–84.2) | 60 | 43.1 (11–204) | 76 | 8.0 (4.5–46.5) |
| Duration of diabetes (years) | 300 | 7 (3–15) | 100 | 3 (2–8) | 100 | 19 (10–28) | 100 | 4 (2–10) | |
| Age at diagnosis of diabetes (years) | 300 | 46 (40–54) | 100 | 48 (43–54) | 100 | 54 (46.5–61.5) | 100 | 49 (40–56) | |
| Comorbidities | |||||||||
| T2DM only | 151 | 50 | 66 | 66 | 23 | 23 | 62 | 62 | |
| 1 Comorbidity | 113 | 38 | 30 | 30 | 50 | 50 | 33 | 33 | |
| 2 Comorbidities | 29 | 10 | 4 | 4 | 21 | 21 | 4 | 4 | |
| 3 Comorbidities | 7 | 2 | 0 | 0 | 6 | 6 | 1 | 1 | |